# Health Economic Impact Summary

## Gene Therapy Impacts

### 1. Follistatin Therapy (2 lb muscle gain, 2 lb fat reduction)
See [detailed report](follistatin_impact.md)
- Healthcare cost reduction from obesity impacts
- Workforce productivity improvements
- Medicare savings from reduced comorbidities

### 2. Lifespan Extension (2.5%)
See [detailed report](lifespan_impact.md)
- GDP increase from extended workforce participation
- Medicare savings from delayed age-related care
- Economic value of additional healthy years

### 3. Klotho Therapy
See [detailed report](klotho_impact.md)
- Cognitive function value (2-5 IQ points)
- Dementia care cost reduction (2-year delay)
- Medicare savings from delayed ESRD

## Clinical Study Considerations
See [detailed report](study_design.md)
- Biomarker correlation analysis
- Age group stratification recommendations
- Follow-up duration requirements

## Implementation Framework
See sensitivity analysis reports:
- [Follistatin Sensitivity](follistatin_sensitivity.md)
- [Klotho Sensitivity](klotho_sensitivity.md)
- [Lifespan Sensitivity](lifespan_sensitivity.md)

## Reference Documentation
- [2-lb-fat-reduction](references\2-lb-fat-reduction.md)
- [economic-modeling](references\economic-modeling.md)
- [klotho-50-50-savings](references\klotho-50-50-savings.md)
- [klotho-dose-response](references\klotho-dose-response.md)
- [klotho-neuroinflammation](references\klotho-neuroinflammation.md)
- [klotho-savings](references\klotho-savings.md)
- [klotho](references\klotho.md)
- [muscle-fat](references\muscle-fat.md)
